Medical Cyclotron Market Report 2025 (Global Edition)

Global Medical Cyclotron Market Report 2025 Market Size Split by Product Type (Cyclotron 10-12MeV, Cyclotron 16-18MeV, Cyclotron 19-24MeV, Cyclotron above 24MeV), by Application (Oncology, Neurology, ...

Medical Cyclotron Market Report Description

We have various report editions of Medical Cyclotron Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape: Medical Cyclotron market

The global medical cyclotron market is fragmented, with the presence of several players. Key players have adopted strategies such as partnerships and mergers & acquisitions to increase market share. 

GE Healthcare, IBA Radiopharma Solutions, Sumitomo Heavy Industries, Ltd., Advanced Cyclotron Systems, Siemens Healthineers AG, and Best Cyclotron Systems, Inc. are prominent players in the medical cyclotron market. 

Recent Market Developments:

• In April 2023, GE HealthCare and Axim Life Isotopes South Africa (ALISA) partnered to expand molecular imaging access in South Africa and improve precision care. The partnership will deliver two cyclotrons to ALISA's laboratory, enabling the production of radiopharmaceuticals for early diagnosis and treatment effectiveness in diseases such as cancer, cardiovascular, and neurological 

(Source: https://www.itnonline.com/content/ge-healthcare-and-axim-life-isotopes-south-africa-alisa-collaborate-expand-access-molecular)

• In 2021, GE Healthcare announced the expansion of its radiopharmacy network to support the development of novel therapies and diagnostics for cancer and other diseases. The company aims to build a network of cyclotron and radiopharmacy facilities worldwide to improve access to radiopharmaceuticals for patients. 

(Source;https://www.gehealthcare.com/about/newsroom/press-releases/ge-healthcare-advances-precision-health-theranostics-with-new-products-solutions-at)

Top Companies Market Share in Medical Cyclotron Industry: (In no particular order of Rank)

• IBA Radiopharma Solutions
• Advanced Cyclotron Systems
• Best Cyclotron Systems Inc.
• Best ABT Molecular Imaging Inc.
• Siemens Healthineers
• GE Healthcare
• IONETIX Corporation
• PMB-ALCEN
• Sumitomo Heavy Industries Ltd.
• and The Japan Steel Works
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Which Region will dominate the Market in 2024, and Which Region is Expanding at the Fastest CAGR?

The North American region has dominated the Medical Cyclotron Market. North American regions hold around. In terms of value, North America held XX% share of the global Medical Cyclotron market. North America dominated the global market in 2022. This is ascribed to the availability of advanced healthcare infrastructure, the presence of prominent pharmaceutical & biotechnology firms, and substantial investment in research & development. According to the Centers for Disease Control and Prevention (CDC), chronic diseases such as cancer, heart disease, and diabetes affect over 80% of American adults. This high prevalence fuels demand for diagnostic imaging tools such as PET scans that rely on cyclotrons for radioisotope production.  Due to the increasing demand for nuclear scans, and the growing number of cancer patients, the region will continue to dominate the market throughout the forecast period. The region’s market is also growing due to increased investments in healthcare infrastructure, the shutting down of nuclear reactors, and the increasing demand for cost-effective solutions.

The European Medical Cyclotron Market is anticipated to grow at the fastest CAGR from 2023 to 2032. As per the medical cyclotron market forecast, the industry in Europe is likely to expand at a high CAGR during the forecast period. Advancements in medical technologies play a significant role in identifying cancer and diabetes at early stages, leading to improved treatment outcomes. Early detection enables for more targeted and personalized therapies, enhancing patient response and survival rates. Europe is expected to have the second-largest volume share during the forecast period. Due to high cancer prevalence, and rising awareness about nuclear scans, and increasing awareness, the region will continue to be a major market player. The International Atomic Energy Agency is an international regulatory body that allows the installation of particle accelerators. The IAEA has strict regulations that must be followed when installing these devices in any European nation. These clearly defined regulatory guidelines are important to ensure patient safety around radioactive devices.

The current report Scope analyzes Medical Cyclotron Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

Medical Cyclotron Market Analysis

How is the Product Type Segment Performing in the Medical Cyclotron Market?

Based on Product Type, the 16-18 MeV segment will dominate the global Medical Cyclotron market in the year 2023. Based on this product type, the market is divided into 10-12 MeV, 16-18 MeV, 19 -24 MeV, and 24 MeV and above.

The 16-18 MeV segment dominated the market in 2022 and accounted for over XX% of the overall market revenue. The segment's expansion can be linked to the rising demand for nuclear scans, the rise in cancer prevalence, and increased public awareness of the disease. The Asia Pacific area has the highest density of cyclotron in 16-18 MeV segment due to rising demand for nuclear scans at medical facilities and diagnostic centers.

Cyclotrons with energies between 10 and 12 MeV also hold a sizable market share. Their widespread utilization for nuclear scans in hospitals and diagnostic facilities can be ascribed to their popularity.

Cyclotrons with energies between 10 and 12 MeV are smaller than those found in other particle accelerators. Since they come in protected and unshielded varieties, healthcare workers have several alternatives. Based on dual-target irradiations, such as proton beam currents of 60 A to 130 A and deuteron beam currents of 60 A, these devices have dual-particle capacity.

The cyclotron 19-24 MeV segment is expected to grow at the fastest CAGR of 12.1 % over the forecast period of 2023-2030. Cyclotron 19-24 MeV can be used for affordable production of single-photon emission computed tomography (SPECT) and Positron Emission Tomography (PET) radioisotopes used for medical purposes and at research institutions. The SPECT isotopes I-123, Ge-68, Ga-67, and In-111 along with several conventional PET isotopes are produced in industrial quantities using these medium-energy, high-current accelerators. They better meet the needs of clients for different products of research, diagnosis, and therapy.

The need for medical cyclotrons is expected to increase as PET-associated medical accelerators become more widely accepted for use in cancer treatment and diagnosis. The prevalence of nuclear scans is rising along with cancer awareness. The global medical cyclotron market is anticipated to be driven by rising nuclear scan demand and rising cancer awareness.

• Cyclotron 10-12MeV
• Cyclotron 16-18MeV
• Cyclotron 19-24MeV
• Cyclotron above 24MeV

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Medical Cyclotron Industry. Request a Free Sample PDF!

Which application segment holds the largest revenue share of the Medical Cyclotron Market?

Based on Application,  the Oncology segment dominated the global Medical Cyclotron market. Based on Application, the global Medical Cyclotron market is segmented into Oncology, neurology, cardiology, and other applications

The biggest revenue share was held by the oncology section in 2021, and it is anticipated that this dominance would persist throughout the projected period. One of the main factors fueling the growth of this market is the rising incidence of cancer in the world. The World Health Organization estimates that cancer will be one of the main causes of mortality worldwide in 2020, accounting for 10 million fatalities. The oncology market is anticipated to expand as a result of the increasing demand for precise and effective diagnostic technologies for the early diagnosis and treatment of cancer.

Throughout the forecast period, the neurology segment is anticipated to have the greatest revenue CAGR. The need for medical cyclotrons in the neurology sector is being driven by the rising prevalence of neurological illnesses like Alzheimer's disease, Parkinson's disease, and multiple sclerosis. The World Health Organization estimates that there are 50 million dementia sufferers globally, and that there are almost 10 million new cases each year. The necessity for early and precise diagnosis of various ailments is projected to drive the neurology market's expansion.

Throughout the projection period, the cardiology segment is also anticipated to experience considerable expansion. The need for medical cyclotrons in the cardiology sector is being driven by the rising prevalence of cardiovascular disorders like heart attack, stroke, and heart failure. Almost 836,546 fatalities in the United States occur each year as a result of cardiovascular disease, according to the American Heart Association. The growth of the cardiology market is anticipated to be fueled by the increasing need for sophisticated diagnostic technologies for the early diagnosis and treatment of cardiovascular illnesses.

• Oncology
• Neurology
• Cardiology
• Others

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Medical Cyclotron Type Segment Analysis

Based on Type, the Fixed cyclotron segments will dominate the global Medical Cyclotron market in the year 2023. Based on this type, the market is divided into fixed and mobile segments.

The fixed medical cyclotrons had a greater revenue share. These cyclotrons are employed for mass manufacturing medicinal isotopes, which have therapeutic and diagnostic uses. Larger hospitals and clinics should use fixed cyclotrons because they can produce a lot of isotopes for many patients and don't require a lot of installation space. Moreover, the cyclotron creates high-purity isotopes necessary for therapeutic and diagnostic purposes.

The mobile medical cyclotron segment, on the other hand, is anticipated to see a greater rate of revenue increase over the projection year. Smaller hospitals and clinics that lack the means or room to establish a fixed cyclotron will find mobile cyclotrons to be the perfect solution because they are portable and compact. Universities and research institutions can create isotopes for their studies by using mobile cyclotrons for research and development.

The rising demand for nuclear medicine and diagnostic imaging techniques, particularly in developing economies, is anticipated to be a major factor in the market expansion for mobile medical cyclotrons. Movable cyclotrons are the best option for nations with limited resources and infrastructure since they provide more flexibility in terms of installation and movement. Technology developments have also increased transportable cyclotrons' effectiveness, dependability, and affordability, which has helped this market sector expand.

In addition, it is anticipated that the need for cyclotron-produced medicinal isotopes would increase as the incidence of cancer and other chronic diseases rises. Throughout the projected period, it is anticipated that medical isotope use will continue to rise for both therapeutic and diagnostic purposes. Radiopharmaceuticals, which are used for diagnosing and treating various disorders, are also made using cyclotrons. Both the stationary and mobile medical cyclotron segments are likely to develop due to the rising need for radiopharmaceuticals.

• Fixed Cyclotron
• Mobile Cyclotron

Medical Cyclotron End-Users Segment Analysis

Based on End-users, the hospital segments will dominate the global Medical Cyclotron market in the year 2023. Based on these end-users, the market is divided into Hospital, Specialized Clinics, Pharmaceutical Companies

The hospital segment will dominate by XX% of total market revenue in 2023. Medical Cyclotron Market data indicates a range of end users that contribute significantly to its widespread adoption. Healthcare facilities and clinics primarily rely on medical cyclotrons for producing radioisotopes needed for imaging procedures like PET scans.

Research institutions and laboratories play a pivotal role in driving innovation, discovering novel applications, and expanding medical cyclotron capabilities for scientific experiments and studies. Pharmaceutical and biotech firms use accelerators for producing radioisotopes necessary for drug research as well as creating diagnostic and therapeutic agents.

Specialized cancer treatment centers at the forefront of precision medicine rely heavily on medical cyclotrons as both diagnostic and therapeutic tools in providing cancer care services. Radiopharmaceutical production facilities play a crucial role in meeting public health initiatives by creating reliable supplies of radiopharmaceuticals for disease diagnosis, surveillance and research efforts. Cyclotrons play an integral part in supporting government institutions’ public health efforts through supporting disease surveillance, diagnosis and research programs.

• Hospitals
• Pharmaceutical Companies
• Spcialzed Clincs

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion